CD28 and graft versus host disease: Two SNPs (rs3181096 and rs3181098 in CD28) and four SNPs (rs4553808, rs62182595, rs16840252, and rs5742909 in CTLA4) were associated with the protective effects on the development of GVHD in patients with AML and ALL, respectively.